Antipsychotics Flashcards
First-generation Antipsychotics
Prototype
Chlorpromazine (Thorazine)
Haloperidol (Haldol)
Fluphenazine (Prolixin)
Thiothixene (Navane)
Perphenazine (Trilafon)
Loxapine (Lotxitane)
Trifluoperazine (Stelazine)
First-generation Antipsychotics
Indication
Controls positive manifestations of psychotic disorders:
Schizophrenia
Bipolar
Tourette
Agitation
Nausea prevention (blocks dopamine in CTZ)
First-generation Antipsychotics
MOA
Blocks dopamine (D2), acetylcholine, histamine, and norepinephrine receptors in the brain and PNS
Inhibition of positive symptoms due to blockade of dopamien receptors
First-generation Antipsychotics
Adverse effects
- Acute dystonia (potential crisis)
- Parkinsonism (bradykinesia, rigidity, tremors, shuffling gait)
- Akathisia (unable to sit or stand still)
- Tardive dyskinesia (involuntary movements of face and tongue, limbs, or trunk)
- Neuroleptic malignant syndrome (sudden high fever, dysrhythmias, blood pressure fluctuations, muscle regidity, diaphoresis, tachy, LOC change)
- Anticholinergic effects (dry mouth, blurry vision, urinary retention)
- Neuroendocrine effects (gynecomastia, menstrual irregularities)
- Seizures
- Photosensitivity
- Orthostatic hypotension
- Sedation
- Sexual dysfunction
- Agranulocytosis
- Liver impairment
First-generation Antipsychotics
Nursing actions for neuroleptic malignant syndrome
- Stop medication
- Monitor VS
- Use cooling blankets
- Administer antipyretics (tylenol)
- Administer dantrolene
- Administer diazepam for anxiety
- Administer antiarrhythmic if indicated
- Increase fluids
First-generation Antipsychotics
Tardive dyskinesia
- Long term use
- Monitor after 12 months and then every 3 months thereafter
- Valbenazine treats TD
- Can be permanent
- Prevention: use lowest dosage
First-generation Antipsychotics
Nursing actions for acute dystonia
- Monitor for symptoms (severe spasm of tongue, neck, face, or back) between a few hours to 5 days after first dose
- Treat with anticholinergic agents (diphenhydramine)
- Improvement in 5-20 min with IV or IM routes
First-generation Antipsychotics
Contraindications
Coma
Parkinson’s
Liver damage
Breast cancer
Severe hypotension
Dementia
First-generation Antipsychotics
Interactions
- Increases effect of Anticholinergic agents
- Increases effect of CNS depressants (alcohol, opioids, antihistamines)
- Reduced effect when taken with Levadopa
First-generation Antipsychotics
Admin
- only used if tolerated or patient is violent
- IV, IM, or oral
- Improvements can start in a few days
- Assess for EPSs
Second and third generation Antipsychotics
Prototype
Risperidone (Risperdal)
Olanzapine (Zyprexa)
Quetiapine (Seroquel)
Ziprasidone (Geodon)
Clozapine (Clozaril)
Asenapine (Saphris)
Lurasidone (Latuda)
Paliperidone (Invega)
Iloperidone (Fanapt)
3rd Gen:
Aripriprazole (Abilify)
Brexpiprazole (Rexulti)
Cariprazine (Vraylar)
Second and third generation Antipsychotics
Indications
- First-line treatment for schizophrenia for negative and positive symptoms
- Psychotic episodes caused by levodopa
- Bipolar
- Impulse control disorder
Second and third generation Antipsychotics
MOA
2nd gen: block serotonin and dopamine receptors to a lesser degree. Also block NE, histamine, and acetylcholine receptors
3rd gen: Stabilize dopamine system as agonist and antagonist
Second and third generation Antipsychotics
Therapeutic effects
- Relieves positive and negative symptoms
- Reduces deprssion, anxiety, and suicidal ideation
- Improves cognitive issues (poor memory)
- Fewer EPSs because of less dopamine inhibition
- Fewer anticholinergic effects
- Less relapse
Second and third generation Antipsychotics
Adverse effects
- Diabetes
- Weight gain
- High cholesterol
- Orthostatic hypotension
- Anticholinergic effects
- CNS effects: agitation, dizziness, sedation, sleep disturbance
- Mild EPSs - tremor or akathisia
- Elevated prolactin
- Sexual dysfunction